LLY

1,035.95

-1.33%↓

JNJ

205.86

+0.62%↑

ABBV

230.18

+2.78%↑

UNH

339.49

+4.69%↑

AZN

90.88

+0.55%↑

LLY

1,035.95

-1.33%↓

JNJ

205.86

+0.62%↑

ABBV

230.18

+2.78%↑

UNH

339.49

+4.69%↑

AZN

90.88

+0.55%↑

LLY

1,035.95

-1.33%↓

JNJ

205.86

+0.62%↑

ABBV

230.18

+2.78%↑

UNH

339.49

+4.69%↑

AZN

90.88

+0.55%↑

LLY

1,035.95

-1.33%↓

JNJ

205.86

+0.62%↑

ABBV

230.18

+2.78%↑

UNH

339.49

+4.69%↑

AZN

90.88

+0.55%↑

LLY

1,035.95

-1.33%↓

JNJ

205.86

+0.62%↑

ABBV

230.18

+2.78%↑

UNH

339.49

+4.69%↑

AZN

90.88

+0.55%↑

Search

Perspective Therapeutics Inc

Atvērts

2.12 0.95

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

2.05

Max

2.13

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt (spēcīgs)

Prognoze 12 mēnešiem

+427.4% upside

Perspective Therapeutics Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 2. dec. 17:29 UTC

Galvenie tirgus virzītāji
Iegādes, apvienošanās, pārņemšana

Laurentian Bank Shares Hit Two-Year High on Plans for Break-Up, Takeover

2025. g. 2. dec. 16:21 UTC

Peļņas

Scotiabank Aiming for Earnings Growth After Capital Markets Buoy Results in Latest Quarter -- Update

2025. g. 2. dec. 16:18 UTC

Peļņas

Correction to Scotiabank Quarterly Earnings Buoyed Article

2025. g. 2. dec. 23:53 UTC

Tirgus saruna

Nikkei May Rise After Gains on Wall Street -- Market Talk

2025. g. 2. dec. 22:48 UTC

Peļņas

Marvell's Stock Soars On Data Center Forecast -- Barrons.com

2025. g. 2. dec. 22:12 UTC

Tirgus saruna

Australian 3Q GDP To Show Modest Recovery In Play -- Market Talk

2025. g. 2. dec. 22:03 UTC

Tirgus saruna

Minerals 260's Resource Upgrade Looks Impressive -- Market Talk

2025. g. 2. dec. 22:00 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2025. g. 2. dec. 22:00 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2025. g. 2. dec. 22:00 UTC

Tirgus saruna

Fletcher Building Loses Bull Due to Tame Housing-Market Recovery -- Market Talk

2025. g. 2. dec. 21:56 UTC

Peļņas

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2025. g. 2. dec. 21:50 UTC

Tirgus saruna

Tech, Media & Telecom Roundup: Market Talk

2025. g. 2. dec. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 2. dec. 21:50 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 2. dec. 21:44 UTC

Peļņas

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2025. g. 2. dec. 21:38 UTC

Tirgus saruna

Sky Network TV Has Path to Grow Dividend by 33% -- Market Talk

2025. g. 2. dec. 21:19 UTC

Peļņas

Marvell's Stock Drops As Outlook Fails to Impress -- Barrons.com

2025. g. 2. dec. 20:06 UTC

Tirgus saruna

Oil Futures Fall Amid Russia-Ukraine Peace Talks -- Market Talk

2025. g. 2. dec. 19:55 UTC

Tirgus saruna

Natural Gas Futures Fall Amid Uncertain Weather Forecasts -- Market Talk

2025. g. 2. dec. 19:53 UTC

Tirgus saruna
Peļņas

Global Equities Roundup: Market Talk

2025. g. 2. dec. 19:53 UTC

Tirgus saruna
Peļņas

Scotiabank ROE Target Viewed as Possibly Conservative -- Market Talk

2025. g. 2. dec. 19:24 UTC

Tirgus saruna

Analysts Project Uptick in U.S. Ethanol Stocks -- Market Talk

2025. g. 2. dec. 19:06 UTC

Tirgus saruna

Precious Metals Step Back After Silver Sets Record -- Market Talk

2025. g. 2. dec. 18:27 UTC

Iegādes, apvienošanās, pārņemšana

Kraken to Acquire Backed Finance AG

2025. g. 2. dec. 17:20 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 2. dec. 17:20 UTC

Tirgus saruna

Auto & Transport Roundup: Market Talk

2025. g. 2. dec. 15:17 UTC

Tirgus saruna

Natural Gas Extends Gains Amid Cold Weather -- Market Talk

2025. g. 2. dec. 14:47 UTC

Tirgus saruna

BOE Likely to Cut Rates Further, Weakening Sterling -- Market Talk

2025. g. 2. dec. 14:38 UTC

Tirgus saruna

Silver Steps Back From Record Levels -- Market Talk

2025. g. 2. dec. 14:31 UTC

Tirgus saruna
Peļņas

Scotiabank Strong Quarter Driven By Capital Markets Growth -- Market Talk

Salīdzinājums

Cenas izmaiņa

Perspective Therapeutics Inc Prognoze

Cenas mērķis

By TipRanks

427.4% augšup

Prognoze 12 mēnešiem

Vidējais 11.55 USD  427.4%

Augstākais 18 USD

Zemākais 5 USD

Pamatojoties uz 11 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Perspective Therapeutics Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt (spēcīgs)

11 ratings

10

Pirkt

1

Turēt

0

Pārdot

Finanšu rādītāji

$

help-icon Live chat